dobutamine has been researched along with reserpine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Broadley, KJ; Levy, GP; Lumley, P | 1 |
| Ganchev, T; Ilkova, R; Negrev, N | 1 |
| Cheung, H; Schneyer, CA | 1 |
| Francès, H; Simon, P | 1 |
| Ikeo, T; Murata, S; Nagao, T; Nakajima, H; Sato, M | 1 |
| Ideker, RE; Killingsworth, CR; Melnick, SB; Smith, WM; Walcott, GP | 1 |
1 review(s) available for dobutamine and reserpine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for dobutamine and reserpine
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Analysis of the inotropic: chronotropic selectivity of dobutamine and dopamine in anaethetised dogs and guinea-pig isolated atria.
Topics: Animals; Blood Pressure; Catecholamines; Dobutamine; Dogs; Dopamine; Female; Guinea Pigs; Heart Atria; Heart Rate; Heart Ventricles; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Reserpine | 1977 |
Adrenergic dependence of the platelet aggregation in rats.
Topics: Adenosine Diphosphate; Adrenergic beta-Agonists; Albuterol; Animals; Dobutamine; Male; Platelet Aggregation; Practolol; Rats; Rats, Inbred Strains; Reserpine; Sympathetic Nervous System | 1990 |
Ca-ATPase activity in salivary glands of rats treated with reserpine, isoproterenol, terbutaline or dobutamine.
Topics: Animals; Calcium-Transporting ATPases; Dobutamine; Enzyme Activation; Female; Isoproterenol; Parotid Gland; Rats; Rats, Inbred Strains; Reserpine; Submandibular Gland; Terbutaline | 1987 |
Reserpine-induced hypothermia: participation of beta 1 and beta 2 adrenergic receptors.
Topics: Animals; Betaxolol; Body Temperature; Clenbuterol; Dobutamine; Ethanolamines; Male; Mice; Propanolamines; Receptors, Adrenergic, beta; Reserpine | 1987 |
Cardiovascular effects of a new positive inotropic agent, (-)-(R)-1-(p-hydroxyphenyl)-2-[(3,4-dimethoxyphenethyl)amino]-ethanol (TA-064) in the anesthetized dog and isolated guinea pig heart.
Topics: Adrenergic beta-Agonists; Anesthesia; Animals; Blood Pressure; Cardiotonic Agents; Dobutamine; Dogs; Ethanolamines; Femur; Guinea Pigs; Heart; In Vitro Techniques; Male; Myocardial Contraction; Perfusion; Phenylephrine; Regional Blood Flow; Reserpine; Stereoisomerism | 1984 |
Effects of burst stimulation during ventricular fibrillation on cardiac function after defibrillation.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Animals; Blood Pressure; Dobutamine; Electric Countershock; Heart; Heart Rate; Reserpine; Swine; Sympathetic Nervous System; Timolol; Ventricular Fibrillation; Ventricular Pressure | 2003 |